This one has a reasonably settled answer, so here it is. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.

COA_Karl said:

The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.

No disagreement with COA_Karl. One condition attached. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

MASHdoc_SA said:

I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…

Can confirm the pattern MASHdoc_SA describes. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.

Clinical perspective, offered as context rather than as advice.

Shot day Friday report relevant to baseline bloodwork:

Week 30. Currently on 5mg. Down 36 lbs from starting weight of 248 lbs.

This week's observations: Slight injection site redness, resolved in 24h.

Labs due next week — looking forward to seeing the metabolic panel. I'll post results in the Lab Results section when they come in.